Vitamin K2 (MK-7)
Menaquinone-7 (MK-7) is the long-chain form of vitamin K2 that activates matrix Gla-protein and osteocalcin, directing calcium to bone rather than arterial walls; evidence from RCTs demonstrates preservation of bone mineral density and reduction of vertebral height loss in postmenopausal women.
Stacks containing Vitamin K2 (MK-7)
Public community stacks that include this ingredient.
A 3-year double-blind RCT (n=244) of MK-7 180 mcg/day found significantly attenuated age-related decline in bone mineral content and BMD at lumbar spine and femoral neck versus placebo, plus reduced vertebral height loss in the lower thoracic region; bone strength indices were also favorably affected.
Meta-analysis of 16 RCTs (n=6,425) found vitamin K2 supplementation significantly improved lumbar spine BMD and reduced fracture incidence after exclusion of one outlier study; undercarboxylated osteocalcin was consistently reduced, indicating enhanced bone mineralization.